Who
Charles Ross Carter
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Ovid Therapeutics; Chief Financial Officer, CERo Therapeutics Holdings; Chief Financial Officer, Icad; CFO and Secretary, Gi Dynamics.
In numbers
- Trades disclosed
- 10
- Buys
- 1
- Sells
- 0
- Bought
- $49K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 0
- First trade
- 19 Sep 2019
- Last trade
- 6 Jul 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jul 2026filed 8 Jul 2026 | OVID Ovid TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | OVID Ovid TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 28 Jun 2024filed 1 Jul 2024 | CERo Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 25 Mar 2024filed 27 Mar 2024 | CERo Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —395,387 at $0.00 | filing |
| 10 Jan 2022filed 18 Jan 2022 | Icadoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 10 Jan 2022filed 12 Jan 2022 | Icadoption or derivative | SEC FORM 4 Code A | $468K75,000 at $6.24 | filing |
| 8 Dec 2021filed 15 Dec 2021 | Icad | SEC FORM 4 Bought | $49K7,000 at $7.05 | filing |
| 2 Aug 2021filed 4 Aug 2021 | Icadoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 9 Mar 2021filed 11 Mar 2021 | Gi Dynamicsoption or derivative | SEC FORM 4 Code D | —385,226 at $0.00 | filing |
| 19 Sep 2019filed 23 Sep 2019 | Gi Dynamicsoption or derivative | SEC FORM 4 Code A | —385,226 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.